Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DR10624 in Severe Hypertriglyceridemia
NCT07693777Phase 3Not yet recruiting
- Sponsor
- Doer Bio
- Start
- Aug 2026
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
A Phase 3 trial of DR10624 in hypertriglyceridemia, sponsored by Doer Bio. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
DR10624
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT07693777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07693777.